FXR & LXR
FXR (farnesoid X receptor) is a nuclear receptor that binds to hormone response elements on DNA, regulating the expression of certain genes when it is activated.
Products Related to FXR & LXR(82)
- GC19448RGX-104 HydrochlorideCAS: 610318-03-1Purity: >99.50%
RGX-104 Hydrochloride is an orally active liver X receptor (LXR) agonist that modulates innate immunity by activating the transcription of the apolipoprotein E (ApoE) gene.
- GC30842Androsterone (5α-Androstan-3α-ol-17-one)CAS: 53-41-8Purity: >95.00%
Androsterone (5α-Androstan-3α-ol-17-one) is a metabolite of testosterone that modulates the susceptibility of an epilepsy seizure.
- GC31314Nagilactone BCAS: 19891-51-1Purity: >98.00%
Nagilactone B is a liver X receptor (LXR) agonist.
- GC31372BMS-779788 (EXEL04286652)CAS: 918348-67-1Purity: >98.00%
BMS-779788 (EXEL04286652) is a LXR partial agonist with IC50 values of 68 nM for LXRα and 14 nM for LXRβ.
- GC31386(-)-PX20606 trans isomer ((-)-PX-102 trans isomer)CAS: 1268244-88-7Purity: >98%
(-)-PX20606 trans isomer ((-)-PX-102 trans isomer) is a FXR agonist with EC50s of 18 and 29 nM for FXR in FRET and M1H assay, respectively.
- GC31395PX20606 trans racemate (PX-102 trans racemate)CAS: 1268244-85-4Purity: >98.50%
PX20606 trans racemate (PX-102 trans racemate) (PX-102 trans racemate) is a FXR agonist with EC50s of 32 and 34 nM for FXR in FRET and M1H assay, respectively.
- GC32459XL041 (BMS-852927)CAS: 1256918-39-4Purity: >99.00%
XL041 (BMS-852927) (BMS-852927) is an LXRβ-selective agonist.
- GC3367324-HydroxycholesterolCAS: 30271-38-6Purity: >98.00%
24-Hydroxycholesterol is a natural sterol, which serves as a positive allosteric modulator of N-Methyl-d-Aspartate (NMDA) receptorsR, and a potent activator of the transcription factors LXR.
- GC34965(20S)-ProtopanaxatriolCAS: 34080-08-5Purity: >98.00%
(20S)-Protopanaxatriol is a metabolite derived from ginsenosides, possessing diverse biological activities and pharmacological effects.
- GC36499LXRβ agonist-2CAS: 1949801-52-8Purity: >98%
LXRβ agonist-2 is a highly potent and β-selective liver X receptor (LXRβ) agonist with EC50 of 7 nM, displays 28.5-fold selectivity over LXRα (EC50=200 nM) and used in the treatment of atherosclerosis.
- GC400535α,6α-epoxy CholestanolCAS: 1250-95-9Purity: >95.00%
5α,6α-epoxy Cholestanol is a cholesterol derivative that can be catalytically generated by the cytochrome P450 enzyme system in mitochondria or induced during lipid peroxidation. 5α,6α-epoxy Cholestanol can regulate the biosynthesis of bile acids and induce the differentiation and death of tumor cells.
- GC4057124(S),25-epoxy CholesterolCAS: 77058-74-3Purity: >95.00%
24(S),25-epoxy Cholesterol is an oxysterol and the most abundant oxysterol in mouse ventral midbrain.
- GC40911Glycine-β-muricholic AcidCAS: 66225-78-3Purity: >98.00%
Glycine-β-muricholic Acid is an effective, stable, and arginine-selective oral bioactive FXR inhibitor. It is the glycine-bound form of the murine primary bile acid β-muricholic acid.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC19448 | RGX-104 Hydrochloride | 610318-03-1 | >99.50% | |
RGX-104 Hydrochloride is an orally active liver X receptor (LXR) agonist that modulates innate immunity by activating the transcription of the apolipoprotein E (ApoE) gene. | ||||
| GC19892 | Sodium chenodeoxycholate | 2646-38-0 | >98.00% | |
A primary bile acid | ||||
| GC30565 | BAR502 | 1612191-86-2 | >98.00% | |
A dual agonist of GP-BAR1 and FXR | ||||
| GC30842 | Androsterone (5α-Androstan-3α-ol-17-one) | 53-41-8 | >95.00% | |
Androsterone (5α-Androstan-3α-ol-17-one) is a metabolite of testosterone that modulates the susceptibility of an epilepsy seizure. | ||||
| GC31314 | Nagilactone B | 19891-51-1 | >98.00% | |
Nagilactone B is a liver X receptor (LXR) agonist. | ||||
| GC31331 | GSK2033 | 1221277-90-2 | >99.00% | |
GSK2033 is a potent LXR antagonist, with IC 50 values of 310nM and 83nM for LXRα and LXRβ, respectively. | ||||
| GC31372 | BMS-779788 (EXEL04286652) | 918348-67-1 | >98.00% | |
BMS-779788 (EXEL04286652) is a LXR partial agonist with IC50 values of 68 nM for LXRα and 14 nM for LXRβ. | ||||
| GC31386 | (-)-PX20606 trans isomer ((-)-PX-102 trans isomer) | 1268244-88-7 | >98% | |
(-)-PX20606 trans isomer ((-)-PX-102 trans isomer) is a FXR agonist with EC50s of 18 and 29 nM for FXR in FRET and M1H assay, respectively. | ||||
| GC31395 | PX20606 trans racemate (PX-102 trans racemate) | 1268244-85-4 | >98.50% | |
PX20606 trans racemate (PX-102 trans racemate) (PX-102 trans racemate) is a FXR agonist with EC50s of 32 and 34 nM for FXR in FRET and M1H assay, respectively. | ||||
| GC32054 | Rovazolac | 1454288-88-0 | >99.50% | |
Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1. | ||||
| GC32459 | XL041 (BMS-852927) | 1256918-39-4 | >99.00% | |
XL041 (BMS-852927) (BMS-852927) is an LXRβ-selective agonist. | ||||
| GC32742 | INT-767 | 1000403-03-1 | >98.00% | |
INT-767 is a potent dual agonist of the farnesoid X receptor (FXR) and the Takeda G protein-coupled receptor 5 (TGR5), with EC 50 values of 30nM and 630nM, respectively. | ||||
| GC32801 | AZ876 | 898800-26-5 | >99.00% | |
An LXR agonist | ||||
| GC33673 | 24-Hydroxycholesterol | 30271-38-6 | >98.00% | |
24-Hydroxycholesterol is a natural sterol, which serves as a positive allosteric modulator of N-Methyl-d-Aspartate (NMDA) receptorsR, and a potent activator of the transcription factors LXR. | ||||
| GC34686 | Nidufexor | 1773489-72-7 | >98.50% | |
Nidufexor is an orally available farnesoid X receptor (FXR) agonist with an EC 50 value of 25nM. | ||||
| GC34965 | (20S)-Protopanaxatriol | 34080-08-5 | >98.00% | |
(20S)-Protopanaxatriol is a metabolite derived from ginsenosides, possessing diverse biological activities and pharmacological effects. | ||||
| GC36499 | LXRβ agonist-2 | 1949801-52-8 | >98% | |
LXRβ agonist-2 is a highly potent and β-selective liver X receptor (LXRβ) agonist with EC50 of 7 nM, displays 28.5-fold selectivity over LXRα (EC50=200 nM) and used in the treatment of atherosclerosis. | ||||
| GC37525 | RGX-104 free Acid | 610318-54-2 | >99.50% | |
| GC37630 | Sevelamer | 52757-95-6 | >98% | |
Sevelamer is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease; consists of polyallylamine that is crosslinked with epichlorohydrin. | ||||
| GC39535 | Yamogenin | 512-06-1 | >98.00% | |
Yamogenin (Neodiosgenin) is a diastereomer of diosgenin. | ||||
| GC40024 | Altenusin | 31186-12-6 | >98.00% | |
Altenusin is a polyphenol fungal metabolite originally isolated from the fungus Alternaria that has diverse biological activities. | ||||
| GC40053 | 5α,6α-epoxy Cholestanol | 1250-95-9 | >95.00% | |
5α,6α-epoxy Cholestanol is a cholesterol derivative that can be catalytically generated by the cytochrome P450 enzyme system in mitochondria or induced during lipid peroxidation. 5α,6α-epoxy Cholestanol can regulate the biosynthesis of bile acids and induce the differentiation and death of tumor cells. | ||||
| GC40571 | 24(S),25-epoxy Cholesterol | 77058-74-3 | >95.00% | |
24(S),25-epoxy Cholesterol is an oxysterol and the most abundant oxysterol in mouse ventral midbrain. | ||||
| GC40911 | Glycine-β-muricholic Acid | 66225-78-3 | >98.00% | |
Glycine-β-muricholic Acid is an effective, stable, and arginine-selective oral bioactive FXR inhibitor. It is the glycine-bound form of the murine primary bile acid β-muricholic acid. | ||||
